Heterocyclic compounds and analogues thereof and their use as inhibitors of Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2), and also to a method for preventing or treating a disease or disorder that can be treated or prevented by modulating the activity of MAPKAP-K2 in a subject and to pharmaceutical compositions and kits that include these MAPKAP-K2 inhibitors.
Heterocyclic compounds which are inhibitors of Mitrogen-Activated Protein Kinase-Activated Protein Kinase-2 (MAPKAP-K2) as described, in addition to their use in the treatment of cytokine mediated diseases.
描述了一类抑制Mitrogen-Activated Protein Kinase-Activated Protein Kinase-2 (MAPKAP-K2)的杂环化合物,除了它们在治疗细胞因子介导的疾病中的应用外。
[EN] Heterocyclic compounds which are inhibitors of Mitrogen-Activated Protein Kinase-Activated Protein Kinase-2 (MAPKAP-K2) as described, in addition to their use in the treatment of cytokine mediated diseases. [FR] La présente invention concerne des composés hétérocycliques qui sont des inhibiteurs de la protéine kinase activée par la protéine kinase activée par le mitogène 2 (MAPKAP-K2). L'invention concerne également leur utilisation dans le traitement de maladies induites par les cytokines.